Endotoxin Testing Update: Recombinant Methods and Clearer Documentation

## A standards development worth following Recombinant reagents are part of an important change in the endotoxin-testing landscape. USP's April 25, 2025 notice identified May 1, 2025 as the official date for General Chapter , which addresses bacterial endotoxin testing using recombinant reagents. The notice names recombinant factor C, or rFC, and recombinant cascade reagent, or rCR, as methodologies covered by the chapter. [USP: Chapter notice and call for data](https://www.uspnf.com/notices-call-for-data-86-20250425) This milestone concerns the recognition and evaluation of testing approaches. It does not mean that every laboratory has adopted the same method or that every material has been examined with recombinant reagents. Readers should continue to identify the actual procedure named in a report. ## A separate update in March 2026 FDA lists a March 2026 revision of its question-and-answer guidance on pyrogen and endotoxin testing. The agency describes its scope in relation to established testing principles and acceptance criteria, including USP Chapter and other referenced standards. This provides a current reference point for the regulated testing context. It should not be read as evidence that a particular research product has been tested or approved. [FDA: updated guidance overview](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pyrogen-and-endotoxins-testing-questions-and-answers) The two developments belong on the same standards-watch reading list, but they are separate documents with separate scopes. A careful update preserves that distinction instead of suggesting that one announcement universally replaces all earlier practice. ## What to look for in the documentation For a laboratory evaluating an unfamiliar report, the practical starting point is the test description. Does it identify the method and applicable chapter? Is the result accompanied by units? Is a reported limit distinguished from an actual measured value? Can the result be traced to the material submitted? Those are editorial review questions, not a substitute for the full method or applicable standard. They help prevent terms such as “tested” or “passes” from becoming detached from the underlying evidence. ## Follow implementation as well as announcements Standards coverage is most useful when it follows both the publication of new approaches and the documentation of their use. For future updates, the relevant questions include which procedures a laboratory adopts, how it describes their suitability, and whether the reporting format makes comparisons understandable. The significance of recombinant testing is a change in the available analytical approaches. Its relevance to any individual research sample must still be established through the actual laboratory record.